Vesper Bio

0 followers


Vesper Biotechnology is a clinical stage biotech company and world leader in sortilin biology. Vesper's VES001 is being developed for FTD(GRN) and is in phase I.

Industries

Employees

11-50

Links


Org chart

Mads Fuglsang Kjolby
Chief Medical Officer
Collapse
Ditte Nedergaard Mikkelsen
Clinical Oversight/clinical Trial Manager

Teams

This company has no teams yet